Please login to the form below

Not currently logged in
Email:
Password:

Creabilis

This page shows the latest Creabilis news and features for those working in and with pharma, biotech and healthcare.

UK biotech gains further £47.2m from Biomedical Catalyst funding

UK biotech gains further £47.2m from Biomedical Catalyst funding

For example, clinical-stage biotech company Creabilis leveraged additional capital alongside its award to fund a large clinical trial in atopic dermatitis.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    175. Creabilis (UK). Sienna. Acquisition. Portfolio of first-in-class topical. 150. Global rights unless stated. ... Deal structure. Comments. Creabilis. Sienna Biopharmaceuticals. $150m. Undisclosed upfront payments. Regulatory and commercial milestone

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics